Search Results - "Jokar, Narges"

Refine Results
  1. 1

    Bench-to-Bedside Theranostics in Nuclear Medicine by Jokar, Narges, Assadi, Majid, Yordanova, Anna, Ahmadzadehfar, Hojjat

    Published in Current pharmaceutical design (01-01-2020)
    “…The optimum selection of the appropriate radiolabelled probe for the right target and the right patient is the foundation of theranostics in personalised…”
    Get more information
    Journal Article
  2. 2

    Precision Medicine Approach in Prostate Cancer by Assadi, Majid, Jokar, Narges, Ghasemi, Mojtaba, Nabipour, Iraj, Gholamrezanezhad, Ali, Ahmadzadehfar, Hojjat

    Published in Current pharmaceutical design (01-01-2020)
    “…Prostate cancer is the most prevalent type of cancer and the second cause of death in men worldwide. Various diagnostic and treatment procedures are available…”
    Get more information
    Journal Article
  3. 3
  4. 4
  5. 5

    Theranostic approach in liver cancer: an emerging paradigm to optimize personalized medicine by Jokar, Narges, Moradhaseli, Farzad, Ahmadzadehfar, Hojjat, Jafari, Esmail, Nikeghbalian, Saman, Rasekhi, Ali Reza, Assadi, Majid

    “…Purpose This review aims to focus an update of the state-of-the-art theranostics approach in liver cancer using 131I, 32P, 90Y, 166Ho, and 186/188Re…”
    Get full text
    Journal Article
  6. 6

    Toward radiotheranostics in cancer stem cells: a promising initial step for tumour eradication by Ghaderi, Farzaneh, Jokar, Narges, Gholamrezanezhad, Ali, Assadi, Majid, Ahmadzadehfar, Hojjat

    “…Purpose This review aims to focus on cancer stem cell (CSC) development and properties, and highlight some of the possible methods of targeting CSCs including…”
    Get full text
    Journal Article
  7. 7

    Radioimmunotherapy (RIT) in Brain Tumors by Gholamrezanezhad, Ali, Shooli, Hossein, Jokar, Narges, Nemati, Reza, Assadi, Majid

    Published in Nuclear medicine and molecular imaging (01-12-2019)
    “…Annually, the incidence of brain tumors has slightly increased and also the patient prognosis is still disappointing, especially for high-grade neoplasms. So,…”
    Get full text
    Journal Article
  8. 8

    A Path to New Normal of Nuclear Medicine Facilities: Considerations for Reopening by Abbasi, Farhad, Gholamrezanezhad, Ali, Jokar, Narges, Assadi, Majid

    “…The stormy clouds of the coronavirus disease 2019 outbreak caused a rapidly spreading epidemic still hanging over the sphere. Any steps to transition toward a…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Theranostic Approach in Breast Cancer: A Treasured Tailor for Future Oncology by Jokar, Narges, Velikyan, Irina, Ahmadzadehfar, Hojjat, Rekabpour, Seyed Javad, Jafari, Esmail, Ting, Hong Hoi, Biersack, Hans-Jürgen, Assadi, Majid

    Published in Clinical nuclear medicine (01-08-2021)
    “…Abstract Breast cancer is the most frequent invasive malignancy and the second major cause of cancer death in female subjects mostly due to the considerable…”
    Get full text
    Journal Article
  12. 12

    Multimodal assessment of regional gray matter integrity in early relapsing-remitting multiple sclerosis patients with normal cognition: a voxel-based structural and perfusion approach by Shooli, Hossein, Nemati, Reza, Chabi, Negar, Larvie, Mykol, Jokar, Narges, Dadgar, Habibollah, Gholamrezanezhad, Ali, Assadi, Majid

    Published in British journal of radiology (01-11-2021)
    “…There is increasing evidence that gray matter (GM) impairment is strongly associated with clinical performance decline. We aim to perform a voxelwise analysis…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    PET tracers in glioblastoma: Toward neurotheranostics as an individualized medicine approach by Dadgar, Habibullah, Jokar, Narges, Nemati, Reza, Larvie, Mykol, Assadi, Majid

    Published in Frontiers in nuclear medicine (2023)
    “…Over the past decade, theragnostic radiopharmaceuticals have been used in nuclear medicine for both diagnosis and treatment of various tumors. In this review,…”
    Get full text
    Journal Article
  16. 16
  17. 17

    State-of-the-art modalities in cardio-oncology: insight from a nuclear medicine approach by Jokar, Narges, Amini, Abdullatif, Ravanbod, Mohammadreza, Barekat, Maryam, Shooli, Hossein, Gholamrezanezhad, Ali, Assadi, Majid

    “…Cancer and cardiovascular disease are the most significant causes of morbidity and mortality worldwide. Although the cancer survival rate has increased due to…”
    Get full text
    Journal Article
  18. 18

    Prognostic Factors in the Survival Rate of Patients with Differentiated Thyroid Cancer by Moulod Abbaszadeh, Ashkan Tangestani, Narges Jokar, Mohammadreza Ravanbod, Mohammadreza KalantarHormozi

    Published in Ṭibb-i junūb (01-07-2020)
    “…Background: Thyroid cancer is the most prevalent malignancy of the endocrine systemcancers. Thyroid cancer has increased faster thatn any other malignancy in…”
    Get full text
    Journal Article
  19. 19
  20. 20